that has progressed on 1 or more endocrine therapies in the metastatic setting. Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

In the study, Enhertu reduced the risk of disease progression or death by 36% compared with chemotherapy in 866 patients with chemotherapy-naïve, HR-positive, HER2-low or -ultralow metastatic breast ...

Specifically, Enhertu (trastuzumab deruxtecan) has been cleared to treat HR-positive, HER2-low metastatic breast cancer – an immunohistochemistry (IHC) score of 1+ or 2+ or negative for in situ ...

In February, Enhertu scored its first phase 3 win in HER2-low breast cancer in the DESTINY-Breast04 trial, which analysts at Credit Suisse said could unlock $3 billion in additional sales for the ...

With Enhertu recently receiving US approval for treating HER2-ultralow breast cancer ... They found that all HER2-negative breast cancer samples, using the traditional clinical HER2-negative ...

Enhertu currently costs around Rs 1.6 lakh per 100-milligram injection. Kindly note the image has been posted only for representational purposes. Photograph: Kind courtesy Thirdman/Pexels.com With ...

What is the moon phase today? Today, Feb. 13, 2025, the moon is 15 days old and is in the Full Moon phase of its lunar cycle. It is 99% illuminated. Moon phases reveal the passage of time in the ...

India's pharma market has introduced 3,151 new brands in the past year, with AstraZeneca's cancer drug Enhertu becoming the top-seller, reflecting a rise in cancer cases. Enhertu, exempted from ...

Phase 1, which has targeted hazardous material including solvents, pesticides, paint, propane tanks and lithium batteries, has been completed across 3,000 sites, according to Tara Fitzgerald ...

By spring of 2024, Phase 1 design engineering services had been completed, and TWM, Inc. was chosen to develop construction plans for Phase 2.